Cinanserin hydrochloride

CAS No. 54-84-2

Cinanserin hydrochloride( SQ 10643 )

Catalog No. M26649 CAS No. 54-84-2

Cinanserin hydrochloride is a high affinity antagonist of the 5-HT2 receptor (Ki: 41 nM) and a 3C-like protease inhibitor of severe acute respiratory syndrome coronavirus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 113 In Stock
5MG 65 In Stock
10MG 104 In Stock
25MG 207 In Stock
50MG 369 In Stock
100MG 555 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cinanserin hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Cinanserin hydrochloride is a high affinity antagonist of the 5-HT2 receptor (Ki: 41 nM) and a 3C-like protease inhibitor of severe acute respiratory syndrome coronavirus.
  • Description
    Cinanserin hydrochloride is a high affinity antagonist of the 5-HT2 receptor (Ki: 41 nM) and a 3C-like protease inhibitor of severe acute respiratory syndrome coronavirus.(In Vitro):Cinanserin and Cinanserin hydrochloride inhibit the catalytic activity of SARS-CoV 3CLpro and HCoV-229E 3CLpro (IC50: 4.68 μM and 5.68 μM). Cinanserin/Cinanserin hydrochloride has a binding affinity to SARS-CoV 3CLpro, HCoV-229E 3CLpro, with the KD values of 49.4 μM/78.0 μM for SARS-associated coronavirus (SARS-CoV) 3CLpro.(In Vivo):Cinanserin (5 mg/kg; intravenous injection; for 2 hours; male Wistar rats) treatment significantly reduces systemic burn edema to shamburn levels.
  • In Vitro
    Cinanserin/Cinanserin hydrochloride have binding affinity to SARS-CoV 3CLpro, HCoV-229E 3CLpro, with the KD values of 49.4 μM/78.0 μM for SARS-associated coronavirus (SARS-CoV) 3CLpro and 18.2 μM/36.6 μM for human coronavirus 229E (HCoV-229E) 3CLpro.The IC50 values of Cinanserin and Cinanserin hydrochloride for inhibiting the catalytic activity of SARS-CoV 3CLpro are calculated as 4.92 μM and 5.05 μM, respectively, The corresponding IC50 values for HCoV-229E 3CLpro are 4.68 μM and 5.68 μM. None of the compounds have inhibitory activity against HRV-14 3Cpro at concentrations up to 200 μM.
  • In Vivo
    Cinanserin (5 mg/kg; intravenous injection; for 2 hours; male Wistar rats) treatment significantly reduces systemic burn edema to shamburn levels. Leukocyte-endothelial interactions are significantly reduced by administration of Cinanserin. Animal Model:Male Wistar rats (250 g) underwent thermal injury Dosage:5 mg/kg Administration:Intravenous injection; for 2 hours Result:Significantly reduced systemic burn edema to shamburn levels.
  • Synonyms
    SQ 10643
  • Pathway
    Microbiology/Virology
  • Target
    Influenza Virus
  • Recptor
    aryl hydrocarbon receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    54-84-2
  • Formula Weight
    376.94
  • Molecular Formula
    C20H25ClN2OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (331.62 mM)
  • SMILES
    Cl.CN(C)CCCSc1ccccc1NC(=O)\C=C\c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ibabao CN, et al. The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells. FEBS Open Bio. 2015 Apr 8;5:308-18.
molnova catalog
related products
  • Oseltamivir phosphat...

    A competitive inhibitor of influenza neuraminidase that prevents new viral particles from being released.

  • Peramivir

    Peramivir (RWJ-270201, BCX-1812) is an inhibitor of influenza neuraminidase that prevents new viral particles from being released; an antiviral agent used to treat and prevent influenza A and influenza B.

  • 34'-Dihydroxyflavone

    34'-Dihydroxyflavone (34'-DHF) is an oral active flavonoid with antiviral activity against Influenza A virus.